Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in visceral metastases dominant metastatic breast cancer
NCT02687490Phase 2Completed
- Sponsor
- Fudan University
- Start
- Feb 2017
- Primary completion
- Dec 2020
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Fudan University. Started Feb 2017; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02687490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687490.